Nebula Research & Development LLC Ptc Therapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 9,492 shares of PTCT stock, worth $526,521. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,492Holding current value
$526,521% of portfolio
0.05%Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
258Shares Held
77.4MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$509 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$431 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$410 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$354 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$266 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.97B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...